Global Influenza Surveillance Network (GISRS) in numbers

Global Influenza Surveillance and Response System (GISRS) members include institutions, formally accepted by WHO, in 114 WHO Member States:

• 144 National Influenza Centres (NICs) – on the frontlines of surveillance and monitoring

• 6 WHO Collaborating Centres for Influenza (CCs) – international centres of excellence that carry out detailed analyses and risk assessment.

•  4 WHO Essential Regulatory Laboratories at the interface of influenza surveillance and vaccine development

• 13 WHO H5 Reference Laboratories (H5RefLabs) at the human–animal interface to support countries and WHO in early detection and confirmation of novel viruses.
 
In 2017: 

• 3,500,000 specimens tested.
• 40,000 virus specimens shared with WHO CCs from more than 110 countries.
• 10,000 viruses characterized by WHO CCs.
• 45 candidate vaccine viruses developed for vaccine development and production.
• 138 countries reported surveillance findings to FluNet.
• 145 countries demonstrated high quality capacity of virus detection.